menu
Your Cart

ITT0144

ITT0144
  • Catalog: ITT0144
  • Gene/Protein: AGXT2L2
  • Product Description: Immunotag™ AGXT2L2 Polyclonal Antibody
385.0000
Price in reward points: 385

Available Options

Immunotag™ AGXT2L2 Polyclonal Antibody
Antibody Specification
Datasheet
Target Protein AGXT2L2
Clonality Polyclonal
Storage/Stability -20°C/1 year
Application WB,IHC-p,ELISA
Recommended Dilution Western Blot: 1/500 - 1/2000. Immunohistochemistry: 1/100 - 1/300. ELISA: 1/10000. Not yet tested in other applications.
Concentration 1 mg/ml
Reactive Species Human,Mouse,Rat
Host Species Rabbit
Immunogen The antiserum was produced against synthesized peptide derived from human AGXT2L2. AA range:341-390
Specificity AGXT2L2 Polyclonal Antibody detects endogenous levels of AGXT2L2 protein.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
Form Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Gene Name AGXT2L2
Accession No. Q8IUZ5 Q8R1K4
Alternate Names AGXT2L2; PP9286; 5-phosphohydroxy-L-lysine phospho-lyase; Alanine--glyoxylate aminotransferase 2-like 2
Description 5-phosphohydroxy-L-lysine phospho-lyase(PHYKPL) Homo sapiens This is a nuclear gene encoding a mitochondrial enzyme that catalyzes the conversion of 5-phosphonooxy-L-lysine to ammonia, inorganic phosphate, and 2-aminoadipate semialdehyde. Mutations in this gene may cause phosphohydroxylysinuria. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013],
Protein Expression Brain,Muscle,Pancreas,Stomach,
Subcellular Localization mitochondrial matrix,
Protein Function cofactor:Pyridoxal phosphate .,similarity:Belongs to the class-III pyridoxal-phosphate-dependent aminotransferase family.,subunit:Homotetramer.,
Usage For Research Use Only! Not for diagnostic or therapeutic procedures.
Material Safety Data Sheet
English_US
Danish
Dutch
English_UK
French
German
Spanish
Norwegian
Portuguese
Finnish
Swedish
Polish

Write a review

Note: HTML is not translated!
Bad Good
Captcha

CONNECT WITH US